Description
Turinabol, also known as Oral Turinabol or 4-chlorodehydromethyltestosterone, is an anabolic-androgenic steroid (AAS) first developed in the 1960s in East Germany. It became widely known for its use in state-sponsored doping programs during international sports competitions.
Pharmacologically, Turinabol is a derivative of Dianabol, but it is considered to have milder anabolic effects with lower androgenic activity. Despite this, it has been linked to health risks such as liver toxicity, hormonal disruption, and cardiovascular strain.
Today, Turinabol is a controlled substance in many countries and is included on the World Anti-Doping Agency (WADA) prohibited list. It is not approved for medical use in most regions. Information about Turinabol is generally sought for historical, scientific, or anti-doping education purposes.
